Net Income for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current net income (TTM) is $1.49B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$1.49B
YoY change
+37.2%
5Y CAGR
+17.6%
Peak year (2025)
$1.40B
Cumulative net income
$8.98B
Net Income history chart for ResMed (RMD) from 1993 to 2025
Net Income history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $1.40B | +37.2% | ||
| 2024 | $1.02B | +13.7% | ||
| 2023 | $897.56M | +15.2% | ||
| 2022 | $779.44M | +64.3% | ||
| 2021 | $474.50M | -23.7% | ||
| 2020 | $621.67M | +53.7% | ||
| 2019 | $404.59M | +28.2% | ||
| 2018 | $315.59M | -7.8% | ||
| 2017 | $342.28M | -2.9% | ||
| 2016 | $352.41M | -0.1% | ||
| 2015 | $352.89M | +2.2% | ||
| 2014 | $345.27M | +12.4% | ||
| 2013 | $307.13M | +20.5% | ||
| 2012 | $254.85M | +12.3% | ||
| 2011 | $226.99M | +19.4% | ||
| 2010 | $190.09M | +29.8% | ||
| 2009 | $146.45M | +32.8% | ||
| 2008 | $110.30M | +66.4% | ||
| 2007 | $66.30M | -24.8% | ||
| 2006 | $88.21M | +36.2% | ||
| 2005 | $64.78M | +13.1% | ||
| 2004 | $57.28M | +25.3% | ||
| 2003 | $45.73M | +21.9% | ||
| 2002 | $37.51M | +222.5% | ||
| 2001 | $11.63M | -47.7% | ||
| 2000 | $22.23M | +38.0% | ||
| 1999 | $16.10M | +51.9% | ||
| 1998 | $10.60M | +41.3% | ||
| 1997 | $7.50M | +66.7% | ||
| 1996 | $4.50M | +60.7% | ||
| 1995 | $2.80M | +133.3% | ||
| 1994 | $1.20M | +50.0% | ||
| 1993 | $800,000 | — |
Net Income values are taken from ResMed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, ResMed (RMD) reported net income of $1.40B – surged 37.2% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed net income compounded at +17.6% per year, sustaining 4 straight years of year-over-year growth.
$1.40B stands as the all-time-high annual net income, posted in 2025, against a low of $800,000 during 1993.
Within Healthcare, ResMed (RMD) ranks 9th among 8 peers we track. The peer median for net income is $15.15B.
ResMed Net Income by Year
ResMed Net Income 2025: $1.40B
ResMed net income in 2025 was $1.40B, surged 37.2% from 2024. This figure represents the highest annual value in the available history.
ResMed Net Income 2024: $1.02B
ResMed net income in 2024 was $1.02B, grew 13.7% from 2023.
ResMed Net Income 2023: $897.56M
ResMed net income in 2023 was $897.56M, grew 15.2% from 2022.
ResMed Net Income 2022: $779.44M
ResMed net income in 2022 was $779.44M, surged 64.3% from 2021.
ResMed Net Income 2021: $474.50M
ResMed net income in 2021 was $474.50M.
See more financial history for ResMed (RMD).
Sector peers — Net Income
Companies in the same sector as ResMed, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is ResMed's net income?
- Latest reported net income for ResMed (RMD) is $1.49B (period ending December 31, 2025).
How has ResMed net income changed year-over-year?
- ResMed (RMD) net income changed +37.2% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed net income?
- ResMed (RMD) net income compound annual growth rate is +17.6% over the most recent 5 years available.
When did ResMed net income hit its highest annual value?
- ResMed net income reached its highest annual value of $1.40B in 2025.
What was ResMed net income in 2024?
- ResMed (RMD) net income in 2024 was $1.02B.
What was ResMed net income in 2025?
- ResMed (RMD) net income in 2025 was $1.40B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.